Graham Capital Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.13M Buy
87,521
+79,380
+975% +$2.89M 0.08% 196
2025
Q4
$264K Buy
+8,141
New +$254K 0.01% 918
2025
Q3
Sell
-62,100
Closed -$1.87M 1312
2025
Q2
$1.87M Buy
62,100
+2,169
+4% +$73.5K 0.03% 380
2025
Q1
$2.45M Buy
+59,931
New +$2.88M 0.04% 267
2024
Q2
Sell
-18,526
Closed -$1.57M 1095
2024
Q1
$1.57M Sell
18,526
-1,084
-6% -$86K 0.03% 298
2023
Q4
$1.47M Buy
+19,610
New +$1.36M 0.03% 278

Other funds holding CRI

Graham Capital Management's CRI Position: Q1 2026 in Review

Graham Capital Management increased its Carter's (CRI) stake by 975% in Q1 2026, buying an estimated $2.89M and bringing the position to 87,521 shares worth $3.13M. The position accounts for 0.08% of the portfolio, ranked #196.

Graham Capital Management first reported a position in CRI in Q4 2023 and has held it in 6 quarters since. 275 funds tracked by Wall St. Rank hold CRI as of Q1 2026.

  • Graham Capital Management held 87,521 shares of Carter's worth $3.13M as of Q1 2026.
  • Graham Capital Management bought 79,380 Carter's shares in Q1 2026, an estimated $2.89M.
  • Carter's made up 0.08% of Graham Capital Management's portfolio in Q1 2026, its #196 holding.
  • Graham Capital Management first reported a position in Carter's in Q4 2023 and has held it in 6 quarters since.
  • 275 funds tracked by Wall St. Rank held Carter's as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.